Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Gelder

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapyD A Hesselink, T van Dam, H J Metselaar, et al.
The British Journal of Dermatology|December 4, 2014
Combining biologics with methotrexate in psoriasis: a systematic reviewJ S van Bezooijen, E P Prens, M S Pradeepti, et al.
Transplantation|September 26, 2001
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppressionB J van der Mast, N M van Besouw, P de Kuiper, et al.
Patient Education and Counseling|December 20, 2015
Kidney transplant patients' attitudes towards self-management support: A Q-methodological studyJ W Grijpma, M Tielen, A L van Staa, et al.
Transplantation|March 4, 1998
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humansT van Gelder, C C Baan, A H Balk, et al.
Clinical and Experimental Immunology|May 3, 2002
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantationN M van Besouw, B J van der Mast, P de Kuiper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2011
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patientsM S Marcolino, E Boersma, N C D Clementino, et al.
Transplantation Proceedings|November 15, 2002
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantationN M van Besouw, A H M M Balk, M van Vliet, et al.
Clinical Pharmacology and Therapeutics|September 12, 2008
Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker usersM J Bijl, L E Visser, R H N van Schaik, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 16, 2016
Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidolL G Franken, B C M de Winter, H J van Esch, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapyD A Hesselink, T van Dam, H J Metselaar, et al.
The British Journal of Dermatology|December 4, 2014
Combining biologics with methotrexate in psoriasis: a systematic reviewJ S van Bezooijen, E P Prens, M S Pradeepti, et al.
Transplantation|September 26, 2001
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppressionB J van der Mast, N M van Besouw, P de Kuiper, et al.
Patient Education and Counseling|December 20, 2015
Kidney transplant patients' attitudes towards self-management support: A Q-methodological studyJ W Grijpma, M Tielen, A L van Staa, et al.
Transplantation|March 4, 1998
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humansT van Gelder, C C Baan, A H Balk, et al.
Clinical and Experimental Immunology|May 3, 2002
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantationN M van Besouw, B J van der Mast, P de Kuiper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2011
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patientsM S Marcolino, E Boersma, N C D Clementino, et al.
Transplantation Proceedings|November 15, 2002
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantationN M van Besouw, A H M M Balk, M van Vliet, et al.
Clinical Pharmacology and Therapeutics|September 12, 2008
Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker usersM J Bijl, L E Visser, R H N van Schaik, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 16, 2016
Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidolL G Franken, B C M de Winter, H J van Esch, et al.
Pageof 17